Cognitive disorders in cancer patients
Number of cancer survivors continues to grow, not just because of earlier detection and treatment, but because of revolutionary new therapies. For many individuals, this changes the landscape from a terminal illness to more of a chronic illness. This perspective has broadened the scope of care from treating the disease alone to managing cancer-related symptoms including mental disorders. Cognitive impairments in patients receiving treatment for cancer have been well documented. These disorders are often multifactorial, especially in the setting of advanced cancer. Its prevalence reaches 75%. To assess cognitive impairment, neuropsychological tests and self-reports are commonly used. For cognitive impairments to alleviate wide spectrum of psychosocial and pharmacological interventions are developed.